dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
kalemapex 15 meq (1620 mg) 30 xr tabs
كاليمابكس 15ملي مكافيء ( 1620مجم ) 30 قرص
potassium citrate · 15 meq + 1620 mg
243EGP
Available
Active ingredient
potassium citrate
Strength
15 meq + 1620 mg
Form
tablet
Manufacturer
multi-apex
Route
oral.solid

Uses

Indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of any etiology, and uric acid lithiasis with or without calcium stones. It alkalinizes the urine and raises urinary citrate levels.

Do not use if

Contraindicated in patients with hyperkalemia or conditions predisposing to hyperkalemia, including chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, and in patients receiving potassium-sparing diuretics or potassium supplements. Also contraindicated in peptic ulcer disease.

Side effects

Common side effects include gastrointestinal complaints such as abdominal discomfort, nausea, vomiting, diarrhea, and loose stools. Serious risk of hyperkalemia exists in susceptible patients, which can cause cardiac arrest.

Warnings

Risk of potentially fatal hyperkalemia in patients with impaired potassium excretion; monitor serum electrolytes and ECG in high-risk patients. Solid forms may cause gastrointestinal obstruction or ulceration; take with plenty of water. Regular monitoring of renal function and serum potassium is mandatory.

How it works

Oral potassium citrate is metabolized to potassium bicarbonate, inducing an alkaline load that increases urinary pH and raises urinary citrate excretion. Increased citrate in urine inhibits calcium salt crystallization (oxalate, phosphate) and reduces uric acid precipitation, thereby preventing stone formation.

Storage

Store at controlled room temperature, 15°C–30°C (59°F–86°F). Keep in tightly closed containers away from moisture.